全文获取类型
收费全文 | 103441篇 |
免费 | 8820篇 |
国内免费 | 5653篇 |
专业分类
耳鼻咽喉 | 1116篇 |
儿科学 | 1304篇 |
妇产科学 | 1480篇 |
基础医学 | 13866篇 |
口腔科学 | 1872篇 |
临床医学 | 12837篇 |
内科学 | 16559篇 |
皮肤病学 | 1830篇 |
神经病学 | 6142篇 |
特种医学 | 4426篇 |
外国民族医学 | 53篇 |
外科学 | 11498篇 |
综合类 | 10845篇 |
现状与发展 | 21篇 |
一般理论 | 25篇 |
预防医学 | 6044篇 |
眼科学 | 3645篇 |
药学 | 10348篇 |
67篇 | |
中国医学 | 4421篇 |
肿瘤学 | 9515篇 |
出版年
2024年 | 269篇 |
2023年 | 1382篇 |
2022年 | 3681篇 |
2021年 | 4886篇 |
2020年 | 3419篇 |
2019年 | 3431篇 |
2018年 | 3707篇 |
2017年 | 3093篇 |
2016年 | 3458篇 |
2015年 | 4911篇 |
2014年 | 5951篇 |
2013年 | 5542篇 |
2012年 | 8176篇 |
2011年 | 8479篇 |
2010年 | 5215篇 |
2009年 | 4105篇 |
2008年 | 5579篇 |
2007年 | 5392篇 |
2006年 | 5363篇 |
2005年 | 5104篇 |
2004年 | 3599篇 |
2003年 | 3221篇 |
2002年 | 2698篇 |
2001年 | 2127篇 |
2000年 | 2104篇 |
1999年 | 2288篇 |
1998年 | 1401篇 |
1997年 | 1350篇 |
1996年 | 1016篇 |
1995年 | 971篇 |
1994年 | 807篇 |
1993年 | 508篇 |
1992年 | 691篇 |
1991年 | 575篇 |
1990年 | 558篇 |
1989年 | 485篇 |
1988年 | 437篇 |
1987年 | 353篇 |
1986年 | 305篇 |
1985年 | 259篇 |
1984年 | 164篇 |
1983年 | 122篇 |
1982年 | 62篇 |
1981年 | 76篇 |
1980年 | 50篇 |
1979年 | 100篇 |
1978年 | 66篇 |
1975年 | 41篇 |
1974年 | 55篇 |
1973年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的:通过调查、分析某二级公立医院员工满意度现状及影响因素,为探寻提升员工满意度路径提供依据。方法:按分层随机抽样法,抽取医院276名员工进行满意度问卷调查,对搜集到的数据进行统计分析。结果:医院员工满意度为(71.26±8.57)分;各维度评分中得分最高的是"领导与管理"维度,为(15.52±2.02)分;最低的是"薪酬与福利"维度,为(12.57±2.77)分。学历和岗位是影响该院员工满意度的主要因素。结论:医院员工满意度处于一般水平,医院应从健全薪酬福利机制、做好职业规划、重视不同群体需求、营造文化氛围等路径入手,提升员工满意度。 相似文献
3.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
4.
卫逸涛肖惠敏谢银环孙丽军 《中华健康管理学杂志》2022,(8):547-552
目的了解老年人生命晚期获知疾病相关信息意向及影响因素。方法2016年10月至2017年6月,采用生命晚期疾病信息意向问卷,利用方便抽样法对福州市中心城区7所养老机构及15个社区的414例年龄≥60岁的老年人进行横断面调查,采用单因素分析、多元线性回归与有序多分类logistic回归分析老年人对疾病相关信息的需求水平、获知程度意向及其影响因素。结果414例老年人疾病相关信息需求得分为(17.1±4.9)分;48.8%(202/414)希望详尽知晓,30.7%(127/414)希望选择性了解,20.5%(85/414)不想知道任何信息;多元线性回归分析显示,年龄、文化程度、是否接受/见过其他生命维持治疗(LSTs)是影响老年人疾病相关信息需求水平的主要因素(标准化回归系数分别为-0.141、0.116、0.115,均P<0.05);有序多分类logistic分析显示,年龄(以60~69岁为参照,70~79岁:OR=0.544,95%CI:0.310~0.957;80~89岁:OR=0.526,95%CI:0.289~0.956)、文化程度(以小学及以下为参照,大专及以上:OR=2.166,95%CI:1.093~4.290)、主要生活费来源(以其他补贴为参照,家人支持:OR=7.303,95%CI:1.157~46.108;退休金:OR=9.288,95%CI:1.502~57.415;公积金/储蓄:OR=15.676,95%CI:2.122~115.793)、是否接受/见过其他LSTs(以是为参照,OR=1.985,95%CI:1.150~3.425)是影响老年人疾病相关信息获知程度意向的主要因素。结论老年人生命晚期获知疾病相关信息的意向程度较高,年龄、文化程度、主要生活费来源、是否接受/见过其他生命维持治疗等是其主要影响因素。 相似文献
5.
6.
Moderate sedatives have been increasingly used to improve patient comfort during flexible bronchoscopy (FB). However, routine use of moderate sedation during FB is controversial because its efficacy and safety are not well established.This study aims to evaluate the efficacy and safety of moderate sedation during FB.A search was made of Medline, EMBASE, and the Cochrane Library to May 2014.Randomized controlled trials (RCTs) and quasi-RCTs were included.The main analysis was designed to examine the efficacy of moderate sedation during FB in sedation than no-sedation.The willingness to repeat FB was significantly more in sedation than no-sedation (odds ratio [OR] 2.30; 95% confidence interval [CI] 1.11–4.73; P = 0.02; I2 = 22.5). The duration of FB was shorter in sedation group than no-sedation group (standardized mean difference [SMD] −0.21; 95% CI −0.38 to −0.03; P = 0.02; I2 = 78.3%). Event of hypoxia was not significantly different between sedation and no-sedation groups (OR 0.86; 95% CI 0.42–1.73; P = 0.67; I2 = 0%). The SpO2 during procedure was not different between sedation and no-sedation groups (SMD −0.14; 95% CI −0.37 to 0.08; P = 0.21; I2 = 49.9%). However, in subgroup analysis without supplemental oxygen, the SpO2 was significantly lower in sedation than no-sedation group (SMD −0.45; 95% CI −0.78 to −0.11; P = 0.01; I2 = 0.0%).According to this meta-analysis, moderate sedation in FB would be useful in patients who will require repeated bronchoscopies as well as safe in respiratory depression. To our knowledge, although the various sedative drugs are already used in the real field, this analysis was the first attempt to quantify objective results. We anticipate more definite and studies designed to elucidate standardized outcomes for moderate sedation in FB. 相似文献
7.
目的以基因表达数据集资料为研究对象,分析BCAN基因在肾透明细胞癌中的表达情况以及对患者预后的影响。方法在Oncomine数据库中挖掘BCAN在肾透明细胞癌(ccRCC)中的表达情况。从TCGA数据库中获取ccRCC患者临床资料和目的基因的表达信息并进行统计分析。利用GEO数据库中GSE73731数据集的ccRCC样本进行基因富集分析。利用String数据库分析与BCAN相关的蛋白。结果BCAN低表达组的ccRCC患者在病理分期及T分期方面低于高表达组(P<0.001;P=0.001);N分期及M分期差异无统计学意义(P>0.05)。BCAN低表达组患者的总生存期优于高表达组(P=0.033)。BCAN基因高表达组的样本主要富集在KRAS信号通路。结论BCAN可以通过多种途径来促进肿瘤细胞的侵袭能力,有望成为ccRCC不良预后的重要生物标志物之一。 相似文献
8.
9.
10.